P53-bindendes Polypeptid

Patent europeic · EP1947113 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1947113
Numer da la dumonda
EP08153666
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
03-10-2003
Publitgà
23-07-2008
Concedì
14-12-2011
Stritgà
31-10-2013
Motiv
Taxa annuala betg pajada
Classas IPC
C07K 14/47 (2006.01)
A61K 38/16 (2006.01)
Prioritad
GB 0223193 07.10.2002
GB 0306261 19.03.2003
Derivà da
EP03756559
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 21-05-2014

    Stritgà, taxa betg pajada

    Published in Swissreg on 21.05.2014

  2. 14-12-2011

    Concedì

    Published in Swissreg on 14.12.2011

Partidas

Possessur

Ludwig Institut für Krebsforschung AG

Ludwig Institute for Cancer Research Ltd

Stadelhoferstrasse 22, 8001 Zürich

Genome Research Limited

The Welcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, GB

UCL Cruciform Limited

Gower Street, London WC1E 6BT, GB

Inventur

Lu, Xin Ludwig Institute for Cancer Research

London, Greater London W2 1PG, GB

Kuwabara, Patricia Genome Research Limited

Cambridge, CB10 1SA, GB

Selwood, David

London, Greater London WC1E 6BT, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.